01:52 PM EST, 02/28/2025 (MT Newswires) -- BMO remains Outperform-rated on Kinaxis ( KXSCF ) following fourth-quarter results that beat consensus on SaaS revenue and EBITDA, while FY2025 guidance was a hair light on SaaS revenue and a hair above on EBITDA.

Analyst Thanos Moschopoulos notes that Kinaxis ( KXSCF ) had a record quarter of new ARR bookings, a strong recovery from weakness in the third quarter, which was partly helped by a growing mix of expansion deals.

"We've raised our FY2025E EBITDA and have otherwise made minor changes to our model. We view valuation as attractive, and believe the uncertainty pertaining to the CEO transition is adequately priced in."

BMO has a target of $190 on Kinaxis ( KXSCF ).

Price: 154.95, Change: -5.64, Percent Change: -3.51